| Scorecard |
|---|
|
4 / 5 Stars
|
|
Lipper
4
4
4
5
2
|
|
Zacks Investment Research
1
(Strong Buy)
|
|
Standard & Poor's
5 / 5 Stars
|
|
TheStreet.com
B-
(Buy)
|
Fund Holdings
Management invests in undervalued companies. Lately, the fund has been heavy on healthcare picks and light on financial companies.
Asset Allocation
| % Long | % Net | |
|---|---|---|
| Cash | 2.45 | 2.45 |
| Stocks | 92.78 | 92.78 |
| Bonds | 0.0 | 0.0 |
| Other | 0.0 | 0.0 |
| Foreign Bonds | 0.0 | 0.0 |
| Foreign Stocks | 4.77 | 4.77 |
| Convertible | 0.0 | 0.0 |
| Preferred | 0.0 | 0.0 |
Updated 03.31.2013
Top 10 Holdings
Performance as of 05.31.2013
Portfolio as of 03.31.2013
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| Bristol-Myers Squibb Company | BMY | 48.17 | 4.75 |
| Pfizer Inc | PFE | 12.56 | 4.63 |
| Intel Corp | INTC | 24.59 | 3.6 |
| Genuine Parts Company | GPC | 22.74 | 3.57 |
| Chevron Corp | CVX | 16.51 | 3.53 |
| General Electric Co | GE | 13.53 | 3.35 |
| Dow Chemical Co | DOW | 7.21 | 3.29 |
| Parker Hannifin Corporation | PH | 17.16 | 3.27 |
| Avery Dennison Corp | AVY | 25.49 | 3.25 |
| Cisco Systems Inc | CSCO | 24.94 | 3.09 |
